Inflammatory cytokines, such as TNF, are also able to depolarize M2-type protective NLC (decreasing CLL cell viability), an effect which is countered by IL-10 or blocking antibodies. The gene discussed is IL10; the disease is B-cell chronic lymphocytic leukemia.